EFX vs FOLD · P/E 54, rev $5.68B vs rev $528.3M
Equifax Inc (EFX) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the EFX and FOLD stock pages for the full models.
Not investment advice.